Head-to-head · WeighScore
Noom Med vs TeleClinic
The verdict
Noom Med takes it — 68.3/100 to 60.8/100.
Noom Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Noom Med integrates GLP-1 medication access with Noom's proven cognitive behavioral therapy curriculum, 1-on-1 dietitian coaching, and dedicated care team — the most comprehensive psychology-plus-medication…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Noom Med | TeleClinic |
|---|---|---|
| WeighScore | 68.3/100 | 60.8/100 |
| Grade | C | C |
| Scorecard rank | #155 | #314 |
| Semaglutide | Not disclosed | $199/mo (compounded) |
| Tirzepatide | Not disclosed | $299/mo (compounded) |
| Coverage | Coverage not published | 47 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #155 · C
Strengths
- Combines GLP-1 medication with CBT behavior change
- Dedicated dietitian included in every plan
- Highest support score in fitness app category
- Integrated care team for medication and coaching
- Noom's proven behavioral curriculum
Where it loses points
- Available in only 40 states — excludes AK, HI, ID, MT, NM, SD, VT, WV, WY, ND
- More expensive than app-only alternatives
- Requires commitment to both medication and coaching program
Graded #314 · C
Strengths
- Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
- LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
- Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing
Where it loses points
- Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
- Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
- Not available in California, South Carolina, or New Jersey
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.